Expression of the Fas ligand in cells of T cell lineage
- PMID: 7706720
Expression of the Fas ligand in cells of T cell lineage
Abstract
Fas ligand (FasL) is a membrane-type cytokine belonging to the TNF family, and induces apoptosis through its cell-surface receptor, Fas. To determine the cell types that express FasL, various mouse tissues and cell lines were examined by Northern hybridization using a mouse FasL cDNA as a probe. Among tissues, lymphoid organs (thymus, lymph node, spleen), lung, and small intestine express low levels of FasL mRNA, suggesting the role of FasL in the general immune system and mucosal immunity. The testis expressed FasL mRNA most abundantly; however, the size of FasL mRNA in the testis was slightly shorter than those in other tissues. Distribution of FasL mRNA in a panel of cell lines indicated that the FasL expression is rather restricted to the cells of T cell lineage. Activation of the splenocytes with the T cell activators such as PMA and ionomycin, Con A, anti-CD3, or even IL-2 alone induced the expression of the FasL. CD8+ splenocytes expressed the FasL more abundantly than did the CD4+ splenocytes upon activation by Con A and IL-2. Among CD4+ CTL cell lines, the FasL was expressed in all Th1 and Th0, and some Th2 clones.
Similar articles
-
Th1 and Th2 subsets equally undergo Fas-dependent and -independent activation-induced cell death.Eur J Immunol. 1997 Aug;27(8):1858-64. doi: 10.1002/eji.1830270807. Eur J Immunol. 1997. PMID: 9295019
-
IL-2 induces Fas ligand/Fas (CD95L/CD95) cytotoxicity in CD8+ and CD4+ T lymphocyte clones.J Immunol. 1997 Jun 15;158(12):5612-8. J Immunol. 1997. PMID: 9190908
-
Autocrine and paracrine apoptosis are mediated by differential regulation of Fas ligand activity in two distinct Jurkat T cell populations.J Immunol. 1998 Jun 1;160(11):5288-93. J Immunol. 1998. PMID: 9605126
-
Constitutive Fas ligand expression in several non-lymphoid mouse tissues: implications for immune-protection and cell turnover.Behring Inst Mitt. 1996 Oct;(97):156-60. Behring Inst Mitt. 1996. PMID: 8950473 Review.
-
Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killing.J Immunol. 1998 Aug 1;161(3):1220-30. J Immunol. 1998. PMID: 9686582
Cited by
-
Fas engagement induces the maturation of dendritic cells (DCs), the release of interleukin (IL)-1beta, and the production of interferon gamma in the absence of IL-12 during DC-T cell cognate interaction: a new role for Fas ligand in inflammatory responses.J Exp Med. 2000 Dec 4;192(11):1661-8. doi: 10.1084/jem.192.11.1661. J Exp Med. 2000. PMID: 11104808 Free PMC article.
-
Th1 CD4+ lymphocytes delete activated macrophages through the Fas/APO-1 antigen pathway.Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):11225-9. doi: 10.1073/pnas.92.24.11225. Proc Natl Acad Sci U S A. 1995. PMID: 7479970 Free PMC article.
-
Cytosolic phospholipase A(2)α protects against Fas- but not LPS-induced liver injury.J Hepatol. 2011 Dec;55(6):1281-90. doi: 10.1016/j.jhep.2011.03.017. Epub 2011 Apr 14. J Hepatol. 2011. PMID: 21703211 Free PMC article.
-
The cytocidal activity of OK-432-activated mononuclear cells against human glioma cells is partly mediated through the Fas ligand/Fas system.Jpn J Cancer Res. 1996 Sep;87(9):972-6. doi: 10.1111/j.1349-7006.1996.tb02128.x. Jpn J Cancer Res. 1996. PMID: 8878461 Free PMC article.
-
A bcl-2 transgene expressed in hepatocytes protects mice from fulminant liver destruction but not from rapid death induced by anti-Fas antibody injection.J Exp Med. 1996 Mar 1;183(3):1031-6. doi: 10.1084/jem.183.3.1031. J Exp Med. 1996. PMID: 8642244 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous